These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 11837975)
21. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments. Coombes AG; Tasker S; Lindblad M; Holmgren J; Hoste K; Toncheva V; Schacht E; Davies MC; Illum L; Davis SS Biomaterials; 1997 Sep; 18(17):1153-61. PubMed ID: 9259512 [TBL] [Abstract][Full Text] [Related]
22. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing. Witschi C; Doelker E J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930 [TBL] [Abstract][Full Text] [Related]
23. A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in DL-PLG microparticles using supercritical fluids. Ghaderi R; Artursson P; Carlfors J Eur J Pharm Sci; 2000 Mar; 10(1):1-9. PubMed ID: 10699378 [TBL] [Abstract][Full Text] [Related]
25. The mechanism of PLA microparticle formation by water-in-oil-in-water solvent evaporation method. Chen JL; Chiang CH; Yeh MK J Microencapsul; 2002; 19(3):333-46. PubMed ID: 12022499 [TBL] [Abstract][Full Text] [Related]
26. Acceleration of Final Residual Solvent Extraction From Poly(lactide-co-glycolide) Microparticles. Kias F; Bodmeier R Pharm Res; 2024 Sep; 41(9):1869-1879. PubMed ID: 39147990 [TBL] [Abstract][Full Text] [Related]
27. Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery. Chowdhury DK; Mitra AK Pharm Dev Technol; 2000; 5(2):279-85. PubMed ID: 10810757 [TBL] [Abstract][Full Text] [Related]
28. Biodegradable microparticles of influenza viral vaccine: comparison of the effects of routes of administration on the in vivo immune response in mice. Chattaraj SC; Rathinavelu A; Das SK J Control Release; 1999 Mar; 58(2):223-32. PubMed ID: 10053195 [TBL] [Abstract][Full Text] [Related]
29. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems. Delgado A; Lavelle EC; Hartshorne M; Davis SS Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065 [TBL] [Abstract][Full Text] [Related]
30. Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer. Lee WK; Park JY; Yang EH; Suh H; Kim SH; Chung DS; Choi K; Yang CW; Park JS J Control Release; 2002 Dec; 84(3):115-23. PubMed ID: 12468215 [TBL] [Abstract][Full Text] [Related]
31. Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. Coombes AG; Lavelle EC; Jenkins PG; Davis SS Vaccine; 1996 Oct; 14(15):1429-38. PubMed ID: 8994318 [TBL] [Abstract][Full Text] [Related]
32. Sustained release of isoniazid from a single injectable dose of poly (DL-lactide-co-glycolide) microparticles as a therapeutic approach towards tuberculosis. Dutt M; Khuller GK Int J Antimicrob Agents; 2001 Feb; 17(2):115-22. PubMed ID: 11165115 [TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid). Gao P; Ding P; Xu H; Yuan Z; Chen D; Wei J; Chen D Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):89-93. PubMed ID: 16394556 [TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique. Zhu KJ; Jiang HL; Du XY; Wang J; Xu WX; Liu SF J Microencapsul; 2001; 18(2):247-60. PubMed ID: 11253941 [TBL] [Abstract][Full Text] [Related]
35. Biodegradable poly (DL-lactide glycolide) microparticles as a vehicle for allergen-specific vaccines: a study performed with Ole e 1, the main allergen of olive pollen. Batanero E; Barral P; Villalba M; Rodríguez R J Immunol Methods; 2002 Jan; 259(1-2):87-94. PubMed ID: 11730844 [TBL] [Abstract][Full Text] [Related]
36. Role of poly [DL-lactide-co-glycolide] in development of a sustained oral delivery system for antitubercular drug(s). Ain Q; Sharma S; Garg SK; Khuller GK Int J Pharm; 2002 Jun; 239(1-2):37-46. PubMed ID: 12052689 [TBL] [Abstract][Full Text] [Related]
37. Preparation and characterization of melittin-loaded poly (DL-lactic acid) or poly (DL-lactic-co-glycolic acid) microspheres made by the double emulsion method. Cui F; Cun D; Tao A; Yang M; Shi K; Zhao M; Guan Y J Control Release; 2005 Oct; 107(2):310-9. PubMed ID: 16255081 [TBL] [Abstract][Full Text] [Related]
38. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195 [TBL] [Abstract][Full Text] [Related]
39. Development of microparticles for controlled release of resveratrol to adipose tissue and the impact of drug loading on particle morphology and drug release. Isely C; Hendley MA; Murphy KP; Kader S; Annamalai P; Jabbari E; Gower RM Int J Pharm; 2019 Sep; 568():118469. PubMed ID: 31265884 [TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens. Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]